FDA NDC Directory · JSON-LD · Markdown

Etoposide

NDC 68001-682 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA074529
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsETOPOSIDE (20 mg/mL)
Marketing started20251201
Package count1

External sources

Source: openFDA. Public-domain (CC0).